Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Election Day is Tuesday. What North Carolinians need to know as they head to the polls
Recommended
Count on WRAL on Election Night 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fractyl Health, Inc. - Common Stock
(NQ:
GUTS
)
2.400
-0.160 (-6.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
589,939
Open
2.570
Bid (Size)
2.450 (7)
Ask (Size)
2.610 (24)
Prev. Close
2.560
Today's Range
2.390 - 2.610
52wk Range
1.740 - 14.50
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024
November 04, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024
November 04, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Performance
YTD
-81.32%
-81.32%
1 Month
+4.80%
+4.80%
3 Month
+6.67%
+6.67%
6 Month
-62.15%
-62.15%
1 Year
-81.32%
-81.32%
More News
Read More
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
October 29, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
October 28, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 02, 2024
Via
Benzinga
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
September 24, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Participate in Upcoming September Investor Conferences
September 03, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024
August 14, 2024
Via
InvestorPlace
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 14, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
August 08, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
August 07, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
July 30, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
June 25, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
June 24, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s
June 23, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
June 06, 2024
Via
Benzinga
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
May 29, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
May 20, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
May 13, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
May 13, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
May 08, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
May 07, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
April 30, 2024
From
Fractyl Health, Inc.
Via
GlobeNewswire
The 3 Most Volatile Stocks for Short-Term Traders: April 2024
April 17, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.